← Evidence map

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).

Julie Boucau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

69 papers cite itlatest 60 shown

2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35737946